{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:07:15Z","timestamp":1769879235546,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Platform Program for Advanced Biological Medicine from AMED","award":["JP22am0401002"],"award-info":[{"award-number":["JP22am0401002"]}]},{"name":"JST, CREST","award":["JPMJCR18S4"],"award-info":[{"award-number":["JPMJCR18S4"]}]},{"name":"Research Support Project for Life Science and Drug Discovery (BINDS) from AMED","award":["JP22ama121046"],"award-info":[{"award-number":["JP22ama121046"]}]},{"name":"Joint Research of the Exploratory Research Center on Life and Living Systems","award":["21-101"],"award-info":[{"award-number":["21-101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dystrophin maintains membrane integrity as a sarcolemmal protein. Dystrophin mutations lead to Duchenne muscular dystrophy, an X-linked recessive disorder. Since dystrophin is one of the largest genes consisting of 79 exons in the human genome, delivering a full-length dystrophin using virus vectors is challenging for gene therapy. Human artificial chromosome is a vector that can load megabase-sized genome without any interference from the host chromosome. Chimeric mice carrying a 2.4-Mb human dystrophin gene-loaded human artificial chromosome (DYS-HAC) was previously generated, and dystrophin expression from DYS-HAC was confirmed in skeletal muscles. Here we investigated whether human dystrophin expression from DYS-HAC rescues the muscle phenotypes seen in dystrophin-deficient mice. Human dystrophin was normally expressed in the sarcolemma of skeletal muscle and heart at expected molecular weights, and it ameliorated histological and functional alterations in dystrophin-deficient mice. These results indicate that the 2.4-Mb gene is enough for dystrophin to be correctly transcribed and translated, improving muscular dystrophy. Therefore, this technique using HAC gives insight into developing new treatments and novel humanized Duchenne muscular dystrophy mouse models with human dystrophin gene mutations.<\/jats:p>","DOI":"10.1038\/s41598-023-31481-3","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T23:02:28Z","timestamp":1679007748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model"],"prefix":"10.1038","volume":"13","author":[{"given":"Yosuke","family":"Hiramuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Kazuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuta","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomaru","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Tomizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Oshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kazuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"31481_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","volume":"31","author":"F Fortunato","year":"2021","unstructured":"Fortunato, F., Farn\u00e8, M. & Ferlini, A. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscul. Disord. 31, 1013\u20131020 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"31481_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/proteomes9010009","volume":"9","author":"P Dowling","year":"2021","unstructured":"Dowling, P. et al. The dystrophin node as integrator of cytoskeletal organization, lateral force transmission, fiber stability and cellular signaling in skeletal muscle. Proteomes 9, 1\u201320 (2021).","journal-title":"Proteomes"},{"key":"31481_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen, C. L. et al. The TREAT-NMD DMD global database: Analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum. Mutat. 36, 395\u2013402 (2015).","journal-title":"Hum. Mutat."},{"key":"31481_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1517\/21678707.2015.1088780","volume":"3","author":"J Ramos","year":"2015","unstructured":"Ramos, J. & Chamberlain, J. S. Gene therapy for Duchenne muscular dystrophy. Expert Opin. Orphan Drugs 3, 1255\u20131266 (2015).","journal-title":"Expert Opin. Orphan Drugs"},{"key":"31481_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.dmpk.2018.01.002","volume":"33","author":"D Satoh","year":"2018","unstructured":"Satoh, D. et al. Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics. Drug Metab. Pharmacokinet. 33, 17\u201330 (2018).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"31481_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/mt.2008.253","volume":"17","author":"H Hoshiya","year":"2009","unstructured":"Hoshiya, H. et al. A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol. Ther. 17, 309\u2013317 (2009).","journal-title":"Mol. Ther."},{"key":"31481_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/mt.2009.274","volume":"18","author":"Y Kazuki","year":"2010","unstructured":"Kazuki, Y. et al. Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol. Ther. 18, 386\u2013393 (2010).","journal-title":"Mol. Ther."},{"key":"31481_CR8","doi-asserted-by":"publisher","first-page":"96ra78","DOI":"10.1126\/scitranslmed.3002342","volume":"3","author":"FS Tedesco","year":"2011","unstructured":"Tedesco, F. S. et al. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Sci. Transl. Med. 3, 96ra78 (2011).","journal-title":"Sci. Transl. Med."},{"key":"31481_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbrc.2004.12.191","volume":"328","author":"H Kudoh","year":"2005","unstructured":"Kudoh, H. et al. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Biochem. Biophys. Res. Commun. 328, 507\u2013516 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"31481_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12981-5","volume":"7","author":"N Doorenweerd","year":"2017","unstructured":"Doorenweerd, N. et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"31481_CR11","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1073\/pnas.89.12.5346","volume":"89","author":"D Lederfein","year":"1992","unstructured":"Lederfein, D. et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc. Natl. Acad. Sci. U.S.A. 89, 5346\u20135350 (1992).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"31481_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/gt.2010.147","volume":"18","author":"Y Kazuki","year":"2011","unstructured":"Kazuki, Y. et al. Refined human artificial chromosome vectors for gene therapy and animal transgenesis. Gene Ther. 18, 384\u2013393 (2011).","journal-title":"Gene Ther."},{"key":"31481_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ajhg.2021.12.015","volume":"109","author":"Y Kazuki","year":"2022","unstructured":"Kazuki, Y. et al. A transchromosomic rat model with human chromosome 21 shows robust Down syndrome features. Am. J. Hum. Genet. 109, 328\u2013344 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"31481_CR14","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1074\/jbc.M709410200","volume":"283","author":"PAC \u2019T Hoen","year":"2008","unstructured":"\u2019T Hoen, P. A. C. et al. Generation and characterization of transgenic mice with the full-length human DMD gene. J. Biol. Chem. 283, 5899\u20135907 (2008).","journal-title":"J. Biol. Chem."},{"key":"31481_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/17460441.2020.1718100","volume":"15","author":"NB Wasala","year":"2020","unstructured":"Wasala, N. B., Chen, S.-J. & Duan, D. Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine. Expert Opin. Drug Discov. 15, 443\u2013456 (2020).","journal-title":"Expert Opin. Drug Discov."},{"key":"31481_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aav4324","volume":"5","author":"YL Min","year":"2019","unstructured":"Min, Y. L. et al. CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci. Adv. 5, 1\u201313 (2019).","journal-title":"Sci. Adv."},{"key":"31481_CR17","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","volume":"28","author":"YL Min","year":"2020","unstructured":"Min, Y. L. et al. Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing. Mol. Ther. 28, 2044\u20132055 (2020).","journal-title":"Mol. Ther."},{"key":"31481_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-99535-y","volume":"11","author":"S Abe","year":"2021","unstructured":"Abe, S. et al. Construction of stable mouse artificial chromosome from native mouse chromosome 10 for generation of transchromosomic mice. Sci. Rep. 11, 1\u201312 (2021).","journal-title":"Sci. Rep."},{"key":"31481_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng0697-133","volume":"16","author":"K Tomizuka","year":"1997","unstructured":"Tomizuka, K. et al. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat. Genet. 16, 133\u2013143 (1997).","journal-title":"Nat. Genet."},{"key":"31481_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1262\/jrd.2020-068","volume":"66","author":"Y Wake","year":"2020","unstructured":"Wake, Y. & Kaneko, T. Production of genome-edited mice by visualization of nucleases introduced into the embryos using electroporation. J. Reprod. Dev. 66, 469\u2013473 (2020).","journal-title":"J. Reprod. Dev."},{"key":"31481_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13395-018-0172-z","volume":"8","author":"Y Hiramuki","year":"2018","unstructured":"Hiramuki, Y. & Tapscott, S. J. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage. Skelet. Muscle 8, 1\u20139 (2018).","journal-title":"Skelet. Muscle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31481-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T23:04:12Z","timestamp":1679007852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31481"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31481-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and S.A., H.T., K.M., and S. Takehara are employees of Trans Chromosomics, Inc. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4360"}}